BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22022583)

  • 1. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
    Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
    PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of promyelocytic leukemia protein in human gastric cancers.
    Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
    Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
    Cheng X; Liu Y; Chu H; Kao HY
    J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
    Choi YH; Bernardi R; Pandolfi PP; Benveniste EN
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18715-20. PubMed ID: 17121994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
    Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
    Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
    Xu Z; Chen J; Shao L; Ma W; Xu D
    Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
    Kim YE; Ahn JH
    PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional connection between Rad51 and PML in homology-directed repair.
    Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV
    PLoS One; 2011; 6(10):e25814. PubMed ID: 21998700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
    Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
    J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
    Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
    Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
    Hubackova S; Krejcikova K; Bartek J; Hodny Z
    J Biol Chem; 2012 Aug; 287(32):26702-14. PubMed ID: 22711534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
    Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
    Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6AP promotes the degradation of the PML tumor suppressor.
    Louria-Hayon I; Alsheich-Bartok O; Levav-Cohen Y; Silberman I; Berger M; Grossman T; Matentzoglu K; Jiang YH; Muller S; Scheffner M; Haupt S; Haupt Y
    Cell Death Differ; 2009 Aug; 16(8):1156-66. PubMed ID: 19325566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.